Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.00
Bid: 382.50
Ask: 383.50
Change: 6.00 (1.59%)
Spread: 1.00 (0.261%)
Open: 376.00
High: 383.50
Low: 374.00
Prev. Close: 377.00
CHG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Jan 2023 07:00

RNS Number : 4745N
Chemring Group PLC
23 January 2023
 

FOR IMMEDIATE RELEASE 23 JANUARY 2023

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

DIRECTORATE CHANGE

 

After six years as Chief Financial Officer and a director of the Company, Andrew Lewis has informed the Board of his intention to retire. Andrew's notice period is 12 months; he will continue in role to ensure a smooth transition. 

 

The Board has commenced a search process to identify his successor.

 

Chairman of Chemring, Carl-Peter Forster, commented:

 

"Andrew has been a key member of the executive team during a period where Chemring has strongly repositioned itself. His transformation of the Group's finances has placed it in a good position to take advantage of the many opportunities to continue its growth. The Board thanks him for his contribution to Chemring's success and wishes him every success in the future."

 

 

-ENDS-

 

For further information:

 

Rupert Pittman Group Director of Corporate Affairs, 01794 463401

Chemring Group PLC

 

Oliver Hughes MHP Communications 020 3128 8100

Ollie Hoare

 

Notes to editors

 

· Chemring is a FTSE-250 global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,500 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under two strategic product segments: Sensors & Information and Countermeasures & Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

Remuneration disclosure

 

Andrew Lewis will be treated in accordance with Chemring's approved remuneration policy. He will continue to be paid in line with Chemring's remuneration policy and the treatment of all elements of his remuneration will be in line with the remuneration policy set out in the 2022 Annual Report and Accounts. Full details of all payments made to and receivable by Andrew Lewis will be disclosed on the Chemring website in due course in compliance with Section 430 (2B) of the Companies Act 2006 and in the directors' remuneration report within the Company's Annual Report and Accounts for the year ending 31 October 2023, and subsequent years, as appropriate.

 

www.chemring.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADGGDBGUDDGXD
Date   Source Headline
3rd Aug 20159:28 amRNSTotal Voting Rights
1st Jul 20152:47 pmRNSTotal Voting Rights
24th Jun 20155:26 pmRNSHolding(s) in Company
23rd Jun 20157:00 amRNSHalf Yearly Report
19th Jun 20158:55 amRNSBlocklisting Update
19th Jun 20157:00 amRNSBlocklisting Interim Review
11th Jun 201510:02 amRNSAdditional Listing
2nd Jun 20157:00 amRNSTotal Voting Rights
1st May 201512:01 pmRNSTotal Voting Rights
10th Apr 201511:59 amRNSTotal Voting Rights
19th Mar 20152:21 pmRNSResult of AGM
19th Mar 20157:00 amRNSAGM Statement
2nd Mar 20151:41 pmRNSTotal Voting Rights
2nd Feb 20151:16 pmRNSTotal Voting Rights
27th Jan 20154:10 pmRNSDirector/PDMR Shareholding
27th Jan 20154:09 pmRNSDirector/PDMR Shareholding
27th Jan 20154:08 pmRNSDirector/PDMR Shareholding
27th Jan 201512:25 pmRNSDirector/PDMR Shareholding
27th Jan 201512:11 pmRNSDirector/PDMR Shareholding
27th Jan 201512:08 pmRNSDirector/PDMR Shareholding
27th Jan 201512:03 pmRNSDirector/PDMR Shareholding
23rd Jan 20154:33 pmRNSDirector Declaration
22nd Jan 20157:00 amRNSFULL YEAR RESULTS
2nd Jan 201512:59 pmRNSTotal Voting Rights
30th Dec 20147:00 amRNSDirectorate Change
19th Dec 201410:26 amRNSBlocklisting Interim Review
1st Dec 20141:26 pmRNSHolding(s) in Company
1st Dec 20141:22 pmRNSTotal Voting Rights
25th Nov 20147:00 amRNSPOST-CLOSE STATEMENT
3rd Nov 20142:36 pmRNSTotal Voting Rights
1st Oct 201410:04 amRNSTotal Voting Rights
17th Sep 20147:00 amRNSInterim Management Statement
1st Sep 20142:52 pmRNSTotal Voting Rights
8th Aug 201412:28 pmRNSDirector/PDMR Shareholding
1st Aug 201410:34 amRNSTotal Voting Rights
21st Jul 201410:03 amRNSDirector/PDMR Shareholding
9th Jul 201411:57 amRNSDirector/PDMR Shareholding
2nd Jul 20147:30 amRNSHolding(s) in Company
1st Jul 201412:10 pmRNSDirector/PDMR Shareholding
1st Jul 20149:38 amRNSHolding(s) in Company
1st Jul 20149:00 amRNSChange of Registered Office
24th Jun 20147:00 amRNSDirectorate Change
24th Jun 20147:00 amRNSHalf Yearly Report
18th Jun 201411:00 amRNSBlocklisting Interim Review
30th May 20144:59 pmRNSTotal Voting Rights
27th May 20143:29 pmRNSHolding(s) in Company
27th May 20142:37 pmRNSCompletion of Disposal of European Munitions
22nd May 20147:00 amRNSUpdate on Disposal
12th May 20149:40 amRNSResult of EGM
9th May 20147:00 amRNSACQUISITION OF 3D-RADAR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.